Black patients with ICDs have higher rate of post-implant cardiac events and risk of death

FHS
July 17, 2023
7:12 pm

Black patients with implantable cardioverter defibrillators (ICDs) have a significantly higher burden of disease than white patients with the same device, according to a new study from University of Rochester Medical Center (URMC) cardiology researchers.

Thermo Fisher cuts 2023 forecast, citing volatile economic conditions

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 revenue: $10.57 billion

October 25, 2023

New insights into predictors of organ damage in childhood-onset SLE

Childhood-onset systemic lupus erythematosus (cSLE) is a chronic, severe autoimmune disorder that carries a risk of early organ damage.

June 14, 2024

Ipsen takes on another ADC, this time from a China-based biotech

Ipsen is adding a second antibody-drug conjugate to its plate. The French drugmaker said Thursday that it has inked a global licensing agreement for a

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.